Prognostic value of chemotherapy in addition to concurrent chemoradiotherapy in T3-4N0-1 nasopharyngeal carcinoma: a propensity score matching study.

about

Prognostic value of chemotherapy in addition to concurrent chemoradiotherapy in T3-4N0-1 nasopharyngeal carcinoma: a propensity score matching study.

Item

http://www.wikidata.org/entity/Q46721131

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Prognostic value of chemothera ...... opensity score matching study.

@en

Prognostic value of chemothera ...... opensity score matching study.

@nl

type

Item

label

Prognostic value of chemothera ...... opensity score matching study.

@en

Prognostic value of chemothera ...... opensity score matching study.

@nl

prefLabel

Prognostic value of chemothera ...... opensity score matching study.

@en

Prognostic value of chemothera ...... opensity score matching study.

@nl

P1476

Prognostic value of chemothera ...... opensity score matching study.

@en

P2093

Da-Yong Gu

http://www.w3.org/2001/XMLSchema#string

Dan Zong

http://www.w3.org/2001/XMLSchema#string

Hong-Liang Yu

http://www.w3.org/2001/XMLSchema#string

Jing Wen

http://www.w3.org/2001/XMLSchema#string

Lei Huang

http://www.w3.org/2001/XMLSchema#string

Li Yin

http://www.w3.org/2001/XMLSchema#string

Li-Rong Wu

http://www.w3.org/2001/XMLSchema#string

Ning Jiang

http://www.w3.org/2001/XMLSchema#string

Peng Xie

http://www.w3.org/2001/XMLSchema#string

Peng-Wei Yan

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis.

Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma.

Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients.

The prevalence and prevention of nasopharyngeal carcinoma in China.

Neoadjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: Defining high-risk patients who may benefit before concurrent chemotherapy combined with intensity-modulated radiotherapy.

Prognostic Impact of Plasma Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Treated using Intensity-Modulated Radiation Therapy

Prognostic Value of Neoadjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma with Low Pre-treatment Epstein-Barr Virus DNA: a Propensity-matched Analysis.

Re-evaluation of 6th edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement based on magnetic resonance imaging.

Nasopharyngeal carcinoma: the next challenges.

P304

76807-76815

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.20014

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29100350

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

5652744

http://www.w3.org/2001/XMLSchema#string